Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II

NCT05385250 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Karen-Lise Garm Spindler

Collaborators